Table 5.
Final determination of CCs for standardized testing of second-line antimicrobials in Canada with the M960 system versus the B460 system
Antimicrobial agent | CC (μg/ml) |
|
---|---|---|
B460 | M960 | |
Amikacin | 1 | 1 |
Capreomycin | 1.25 | 2.5 |
Ethionamide | 2.5 | 5 |
Kanamycin | 5 | 2.5 |
Linezolid | 1 | 1 |
Moxifloxacin | 0.5 | 0.25 |
Ofloxacin | 2 | 2 |
PAS | 4 | 4 |
Rifabutin | 0.5 | 0.5 |